about
Functional and Gait Assessment in Children and Adolescents Affected by Friedreich's Ataxia: A One-Year Longitudinal StudyCongenital muscular dystrophies with defective glycosylation of dystroglycan: a population study24 month longitudinal data in ambulant boys with Duchenne muscular dystrophyRobotic and clinical evaluation of upper limb motor performance in patients with Friedreich's Ataxia: an observational study.Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophyClinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker studyVisual development in infants with prenatal post-haemorrhagic ventricular dilatation.Reliability of the North Star Ambulatory Assessment in a multicentric setting.A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy.Congenital muscular dystrophies with cognitive impairment. A population study.Assessment of visual function in children with methylmalonic aciduria and homocystinuria.Cortical visual function in preterm infants in the first year.Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation.The impact of vision on the dynamic characteristics of the gait: strategies in children with blindness.Time to boundary function to assess upright stance in blind children.Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.Longitudinal assessment of visual development in non-syndromic craniosynostosis: a 1-year pre- and post-surgical studyVisual function in infants with non-syndromic craniosynostosisAssessing upper limb function in nonambulant SMA patients: Development of a new moduleNorth Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophyMuscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spineProposal of a clinical score for the molecular test for Pitt-Hopkins syndrome
P50
Q27323220-6ED9E793-BA8B-423C-B814-89229F682B62Q28238656-17E1751D-D233-4F85-9F7F-DAF03B0D7D59Q30000819-EDA4441F-2D27-43D0-84EA-F2267FCEBEDFQ35664661-0DA7EE59-57DD-41A8-81A6-7DCEED86AB7AQ36078440-0E122F82-AE3F-4DEF-B849-A93989450CDCQ36856405-89749ADA-10CC-4327-B4CB-9216C2324C65Q37174851-11D2292A-7D9D-4053-BC62-AF2D682E0767Q37530045-504D3833-F8F8-4644-BFDE-1C40161E6E78Q38019990-3220910D-8B4E-4E36-90D2-DF26E14C264DQ44505558-F7745FEA-2F0D-4D89-942A-10FE26F60C78Q46535906-66CFF8E7-A0D7-445E-94A9-6A5282D1CFBDQ48353164-A6A107BA-BCF4-4334-9054-A55F7DF02E1CQ48530771-324EFBB6-F6E1-442A-933A-A67AF21AFA73Q48746740-95347347-1C27-408C-ACAC-61D0FF614038Q50856305-865C49B2-E2EB-4149-B43B-F60CE67AA789Q51550529-F2B25F1E-B61F-49CE-8FED-0BB480F4D4F9Q56332731-29BEDA09-E4A4-4DB4-95F4-CEE251E4FAD2Q56333598-61DF9004-57E9-4301-AB3D-68757EA0DCF3Q57588237-6ECDDF25-ADE8-4221-B934-304AEC0661A1Q57588250-1F655778-8A74-42E3-9C83-DCD645E4EAC5Q61415100-03877913-A873-449E-BC21-6CE1CA671DE7Q95520734-C4E9D1BF-506C-498F-B5DD-D860A19D4047
P50
description
researcher, ORCID id # 0000-0001-9807-9578
@en
wetenschapper
@nl
name
Gessica Vasco
@ast
Gessica Vasco
@en
Gessica Vasco
@es
Gessica Vasco
@nl
type
label
Gessica Vasco
@ast
Gessica Vasco
@en
Gessica Vasco
@es
Gessica Vasco
@nl
prefLabel
Gessica Vasco
@ast
Gessica Vasco
@en
Gessica Vasco
@es
Gessica Vasco
@nl
P106
P1153
16687278300
P31
P496
0000-0001-9807-9578